Jupiter Life Line Hospitals Ltd Q4 FY2025 Concall Summary

Key Takeaways

• Steady volume-led quarter, margin pressure from depreciation: Total income grew 12.1% YoY on 11.2% volume growth, but PAT dipped 0.9% YoY to ₹44.9 cr solely on higher depreciation.
• Thane restructuring trades beds for surgical capacity: The hospital decommissioned 22 economy ward beds to add 2 OTs, a second MRI, a second cath lab, and expanded daycare, betting that declining length-of-stay makes surgical throughput more valuable than ward capacity.
• Indore occupancy diluted by new beds, ICU held in reserve: Occupancy fell to 42.1% as 78 new beds came online 1 Jan 2025; an 11-bed ICU is built but deliberately uncommissioned until demand justifies it.
• ARPOB growth normalizes to inflation from here: Management explicitly guided that the 10.4% ARPOB growth rate will not continue; Thane and Pune, as mature hospitals, should see only inflation-linked ARPOB growth going forward.
• What to watch next quarter: Whether Indore occupancy begins to absorb the new bed base, any progress on Thane’s environmental clearances for the additional floor, and the pace of Dombivli construction ahead of its Q1 FY27 target.

Thane Reconfiguration: The Capacity Bet

• Ward beds out, surgical infrastructure in: 22 economy ward beds were decommissioned to create space for 2 new operating theatres, a second MRI, a second cardiac cath lab, and an expanded daycare/chemo unit (14 to 22 beds), alongside a new OPD cluster and overhaul of ageing engineering infrastructure including chillers and cooling towers.
• Rationale is clinical, not ARPOB-driven: Management stated the restructuring was done from an occupancy and clinical needs lens, driven by the observation that length of stay for specific procedures and diseases is declining year-on-year with technology advancement, making supporting infrastructure like operating rooms and cath lab space more necessary than ward beds.
• ARPOB impact unquantified: When asked about the expected revenue-per-occupied-bed impact, management said, “I have not done that math… I don’t have an answer to that question, unfortunately.”
• Occupancy ceiling is structural: Thane occupancy sits at 72%, with a mid-70% peak because measurement is at midnight; management sees limited scope to increase further, reinforcing the pivot toward throughput over bed count.

Ankit Thakker: “Yes, ideally, if and when this floor does come up, we definitely think that it should contribute on a unit level a little more to the EBITDA margins because most of the fixed costs are taken care of and the added capacity in terms of manpower, power, etc., does not need as much fixed cost now.”

Expansion Pipeline: Three Hospitals in Motion

• Dombivli on track for Q1 FY27: Construction is progressing as per plan, with ~250 beds in Phase 1 and inauguration expected within a year; ramp-up will play out over the next couple of years.
• Pune at excavation stage: All environmental clearances received; construction expected to begin post-monsoon, with Phase 1 delivering ~250 beds a couple of years after Dombivli. The 500-bed greenfield carries a capex of ~₹500 crores excluding land, which is on a 10-year lease with no escalation and a right to purchase after the third year.
• Mira Road land acquired: Post-purchase regulatory work (7/12 updation) underway; architectural drawings to start shortly.
• Indore Phase 2 gated by occupancy: The next 111-bed expansion will be considered only when occupancy reaches 60-65%, versus the current 40-45% on the expanded base.
• Bed target within sight: The first target of 2,500 beds in Western India is now visible; over the next 4-5 years, as new hospitals become operational, operating cash flows should be sufficient to fund both capex and operations.

Indore: Dilution Today, Levers Tomorrow

• Occupancy diluted by capacity addition: Q4 occupancy fell to 42.1% because 78 new beds were commissioned on 1 January 2025, expanding the denominator while the ramp-up is still in early stages.
• ICU deliberately held back: An 11-bed ICU has been built but is not yet commissioned; management will operationalize it based on occupancy demand, preserving the option to add higher-acuity capacity when volumes justify it.
• ARPOB tailwind has one more year: While Thane and Pune ARPOB growth should be inflation-linked, Indore may see slightly above-inflation ARPOB growth for perhaps one more year due to case mix optimization as the hospital matures.
• Volume growth concentrated in newer units: Thane volume should be stable given its occupancy ceiling; Pune and Indore are where management expects some volume growth.

Balance Sheet & Capital Allocation

• Indore subsidiary debt frees up listed-entity cash: ₹250 cr was raised within the Indore subsidiary (JHPPL) to repay an intercompany loan from the listed entity; this money now becomes available to the listed entity for land purchases or strategic acquisitions.
• Listed entity loan facility sanctioned: A ₹350 cr loan facility has been secured, with ₹75 cr drawn and the remaining ₹275 cr available for capex at Dombivli, Pune, or elsewhere.
• Board comfortable with prudent leverage: Management stated the board is comfortable using debt responsibly to optimize growth in both scale and speed, with the raised debt intended to fund new projects beyond the existing six hospitals.
• Inorganic appetite exists but disciplined: The company is open to both greenfield and acquisition opportunities, with greenfield remaining the preferred choice; management emphasized it will not pursue acquisitions “in a mindless race to add numbers and add speed.” No target multiple was disclosed, described as dynamic and value-dependent.

Ankit Thakker: “The only thing I want to tell you as long as it makes sense in our view, and we will do it, we will not do it just in a mindless race to add numbers and add speed.”

Geographic & Strategic Boundaries

• Western India only, for now: Management stated there is “absolute clarity that we will not go beyond western part of India for now.”
• Mumbai open if sensible: The company is open to opportunities in Mumbai if a sensible one presents itself, though land availability and cost remain the challenge.
• No satellite or OPD-only model: The company does only full-service tertiary care hospitals; the hub-and-spoke model does not suit their operating philosophy.
• Doctor retention holding: Despite competitors starting IT services and Max announcing a new Thane hospital, no senior doctor has left Thane; management reports zero attrition at the senior consultant level, describing teams as strong and sticky.

Ankit Thakker: “So far, not a single one of our senior doctors has moved out and stopped association with us. So we continue to report 0 attrition at the senior consultant level.”

Payer Mix & Revenue Composition

• Payer mix stable: Insurance contributed 55.8% of revenue, self-payers 42.9%, and government schemes just 1.3% in Q4.
• Volume the primary growth engine: FY25 total income grew 17.5%, driven by 11.2% volume growth and 10.4% ARPOB increase, with occupancy improving 150 bps YoY to 65.3%.
• Unit-wise ARPOB undisclosed: Management declined to provide Q4 or annualized ARPOB figures for Thane, Pune, and Indore individually, stating “unit-wise, we are not sharing.”

Guidance & Commitments

Key Metrics